Switch View
© PR Newswire
03.09.2025
ISIN: JP3546800008
Terumo Corporation
45430
LISTED
XJPX
Terumo Neuro stellt neuen neurovaskulären Absaugkatheter SOFIA™ Flow 88 vor - Daten aus EMEA belegen starke Leistung
News Preview
Echte EMEA-Arztpräferenzdaten1 belegen die Nachverfolgbarkeit, Navigation und Gesamtleistung des SOFIA Flow 88 Absaugkatheters bei Schlaganfalleingriffen
MARSEILLE, Frankreich, 3. September 2025 /PRNewswire/ -- Terumo Neuro, ein weltweit führendes Unternehmen für neurovaskuläre Innovationen und eine hundertprozentige Tochtergesellschaft der Teru...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Transaction in Own Shares
News Preview
For immediate release3 September 2025 WORLDWIDE HEALTHCARE TRUST PLC(the "Company") MARKET PURCHASE OF COMPANY'S OWN SHARES This notification is given, pursuant to the authority granted at an Annual General Meeting of the Company held on 9 July 2025 to make market purchases of the Company's own shares up to an aggregate maximum of 69,602,221....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
BioArctic's founders intend to divest minor part of their shareholding
News Preview
STOCKHOLM, Sept. 3, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA-B) has been made aware that the company's two founders and main shareholders, Lars Lannfelt and Pär Gellerfors, intend to divest a minor part of their respective shareholding.
This information is information that BioArctic AB (publ) is obliged to disclose pursua...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
03.09.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
BioArctic's founders intend to divest minor part of their shareholding
News Preview
STOCKHOLM, Sept. 3, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA-B) has been made aware that the company's two founders and main shareholders, Lars Lannfelt and Pär Gellerfors, intend to divest a minor part of their respective shareholding.
This information is information that BioArctic AB (publ) is obliged to disclose pursua...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
03.09.2025
ISIN: JP3546800008
Terumo Corporation
45430
LISTED
XJPX
Terumo Neuro führt Allianz zur Behandlung von Aneurysmen in EMEA ein, um die Zusammenarbeit zwischen Ärzten und die Behandlung von Aneurysmen zu fördern
News Preview
„Wirksame Lösungen zum Leben erwecken" durch eine spezielle EMEA-Initiative, welche die Zusammenarbeit vereinfachen, ein umfassendes Portfolio für Hämorrhagie präsentieren und Ärzte in die Lage versetzen soll, die Ergebnisse für ihre Patienten zu verbessern
MARSEILLE, Frankreich, 3. September 2025 /PRNewswire/ -- Terumo Neuro, ein weltweit führe...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US18914F1030
Clover Health Investments Corp
CLOV
LISTED
NASDAQ
Clover Health CEO Andrew Toy Testifies Before Congress on the Transformative Role of AI in Healthcare, Highlights how Clover is Leading the Way
News Preview
WASHINGTON, D.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) – Clover Health CEO Andrew Toy today had the honor to deliver testimony before the U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health, positioning Clover as a national...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages LifeMD, Inc. (LFMD) Investors To Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025, inclusive (the “Class Period”). LifeMD investors have until October 27, 2025 to file a lead plaintiff motion.
IF YOU...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages Semler Scientific Inc. (SMLR) Investors To Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025, inclusive (the “Class Period”). Semler investors have until October 28, 2025 to file a lead plaintiff moti...
Themefolio
Profiler
Peergroup
© EQS Newswire
03.09.2025
ISIN: CH1175448666
Straumann Holding AG
STMN
LISTED
SIX
Straumann Holding AG raises CHF 250 million through the successful placement of a three-year straight bond
News Preview
Straumann Holding AG
/ Key word(s): Bond/Financing
Straumann Holding AG raises CHF 250 million through the successful placement of a three-year straight bond
03.09.2025 / 18:00 CET/CEST
Basel, September 3, 2025: Straumann Holding AG successfully placed a CHF 250 million straight bond today, which is expected to be ......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.09.2025
ISIN: CH1175448666
Straumann Holding AG
STMN
LISTED
SIX
Straumann Holding AG nimmt durch die erfolgreiche Platzierung einer dreijährigen Anleihe CHF 250 Millionen auf
News Preview
Straumann Holding AG
/ Schlagwort(e): Anleihe/Finanzierung
Straumann Holding AG nimmt durch die erfolgreiche Platzierung einer dreijährigen Anleihe CHF 250 Millionen auf
03.09.2025 / 18:00 CET/CEST
Basel, 3. September 2025: Straumann Holding AG hat heute erfolgreich eine Anleihe über CHF 250 Millionen platziert, di......
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Centene Corporation (CNC) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Sept. 3, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Centene Corporation ("Centene" or the "Company") (NYSE: CNC).
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CENTENE CORPORATION (CNC), CONTACT...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health Inc. (NUTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Sept. 3, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
03.09.2025
ISIN: CA74373X1015
PharmaCorp RX Inc.
PCRX
LISTED
TSX
PharmaCorp to Acquire Two Pharmacies in Western Canada
News Preview
SASKATOON, Saskatchewan, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has entered into definitive share purchase agreements, each dated August 29, 2025 (the “Agreements”), to acquire from the same arm’s length vendors (the “Vendors”) a 100% interest in two Ph...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
Gilead Sciences Breaks Ground on New Manufacturing Hub, a Cornerstone of Its U.S. Growth and Innovation Strategy
News Preview
Gilead Sciences (Nasdaq: GILD) today celebrates the groundbreaking of its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC) at the company’s Foster City headquarters. This milestone marks continued momentum in Gilead’s multi-year strategy to drive growth and scientific leadership across virology, oncology,...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: BMG762791017
Roivant Sciences Ltd
ROIV
LISTED
NASDAQ
Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
News Preview
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today shared an abstract with six-month off-treatment data in uncontrolled Graves’ disease (GD) patients treated with batoclimab for 24 weeks, to be presented at...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Semler Scientific Inc. (SMLR) Investors To Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025, inclusive (the “Cla...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US45258J1025
Immunovant Inc
IMVT
LISTED
NASDAQ
Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
News Preview
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today shared an abstract with six-month off-treatment data in uncontrolled Graves’ disease (GD) patients treated with batoclimab for 24 weeks, to be presented at...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Semler Scientific, Inc. Investors
News Preview
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Semler Scientific, Inc. (“Semler” or the “Company”) (NASDAQ:SMLR) securities during the period of March 10, 2021 through April 15, 2025, inclusive (“the Class Period”).
If you suffered a loss on your Semler investments, yo...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inspire Medical Systems, Inc. - INSP
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE: INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US37733W2044
GSK plc
GSK
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSK
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GSK plc ("GSK" or the "Company") (NYSE: GSK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. ...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US29261A1007
Encompass Health Corp
EHC
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation - EHC
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeMD, Inc. - LFMD
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US90400D1081
Ultragenyx Pharmaceutical Inc
RARE
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ: RARE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. ...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLX
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ: TLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US64049M2098
Neogenomics Inc
NEO
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molina Healthcare, Inc. - MOH
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE: MOH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Simulations Plus, Inc. - SLP
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. ("Simulations Plus" or the "Company") (NASDAQ: SLP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US0162551016
Align Technology, Inc.
ALGN
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Align Technology, Inc. - ALGN
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Align Technology, Inc. ("Align" or the "Company") (NASDAQ: ALGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. ...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lantheus Holdings, Inc. - LNTH
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US0352551081
Anika Therapeutics Inc
ANIK
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ("Anika" or the "Company") (NASDAQ: ANIK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US81728J1097
Sensus Healthcare, Inc.
SRTS
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ: SRTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US5894921072
Mereo BioPharma Group plc
MREO
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc ("Mereo" or the "Company") (NASDAQ: MREO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. ...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US02155H2004
Altimmune Inc
ALT
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ: ALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are enc...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Centene Corporation of Class Action Lawsuit and Upcoming Deadlines - CNC
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Centene Corporation ("Centene" or the "Company")(NYSE: CNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are enco...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: VGG111961055
Biohaven Ltd.
BHVN
LISTED
NYSE
Pomerantz Law Firm Announces the Filing of a Class Action Against Biohaven Ltd. and Certain Officers - BHVN
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Biohaven Ltd. ("Biohaven" or the "Company") (NYSE: BHVN) and certain officers. The class action, filed in the United States District Court for the District of Connecticut, and docketed under 25-cv-01120, is on behalf of a class cons...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US8342033094
Soleno Therapeutics Inc
SLNO
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Unicycive Therapeutics, Inc. ("Unicycive" or the "Company") (NASDAQ: UNCY) and certain officers. The class action, filed in the United States District Court Northern District of California, and docketed under 25-cv-06923, is on beha...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. ("RxSight" or the "Company")(NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encoura...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US74006W2070
Praxis Precision Medicines Inc
PRAX
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAX
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Praxis Precision Medicines, Inc. ("Praxis" or the "Company") (NASDAQ: PRAX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
News Preview
NEW YORK, Sept. 3, 2025 August 6, 2025 (ACCESSWIRE) Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPL
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Replimune Group, Inc. ("Replimune" or the "Company")(NASDAQ: REPL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail a...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers - NUTX
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and certain officers. The class action, filed in the United States District Court for the Southern District of Texas, and docketed under 25-cv- 03999, is on behalf of a cla...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Pomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc. and Certain Officers - ANRO
News Preview
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Alto Neuroscience, Inc. ("Alto" or the "Company") (NYSE: ANRO) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-06105, is on behalf...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US03969K1088
Arcutis Biotherapeutics Inc
ARQT
LISTED
NASDAQ
Arcutis Submits Supplemental New Drug Application for ZORYVE® (roflumilast) Cream 0.3% to Expand Indication for Treatment of Plaque Psoriasis in Children Ages 2 to 5
News Preview
Arcutis Submits Supplemental New Drug Application for ZORYVE® (roflumilast) Cream 0.3% to Expand Indication for Treatment of Plaque Psoriasis in Children...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US04301G1022
Artelo Biosciences, Inc.
ARTL
LISTED
NASDAQ
Artelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2 CAReS Results
News Preview
SOLANA BEACH, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, or neurological conditions, affirms that, based on the strength of the positive interim re...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
News Preview
Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease
Following early access program, customers commend scale, high consistency, and easy sample to insights workflow
Launch follows Illumina's announcement of agreement to acquire SomaLog...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
News Preview
Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease
Following early access program, customers commend scale, high consistency, and easy sample to insights workflow
Launch follows Illumina's announcement of agreement to acquire SomaLog...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
News Preview
Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease
Following early access program, customers commend scale, high consistency, and easy sample to insights workflow
Launch follows Illumina's announcement of agreement to acquire SomaLogic
S...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
News Preview
Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease
Following early access program, customers commend scale, high consistency, and easy sample to insights workflow
Launch follows Illumina's announcement of agreement to acquire SomaLogic
S...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US45337C1027
Incyte Corp
INCY
LISTED
NASDAQ
Incyte Launches HS TRUTHS to Spotlight the True Lived Experience of Hidradenitis Suppurativa
News Preview
Incyte (Nasdaq:INCY) announced the launch of HS TRUTHS, a new educational campaign aimed at revealing the authentic and often hidden realities of living with hidradenitis suppurativa (HS), a chronic inflammatory skin condition. This initiative moves beyond superficial awareness by sharing the physical pain, emotional burden and years-long diagnost...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
CenterWell Home Health Launching 21st Food Fundraising Drive
News Preview
CenterWell Home Health, one of America’s largest home health providers, is preparing to launch its 21st annual Food Fundraising Drive, an effort to fight food insecurity in the communities it serves.
From Sept. 4 through Oct. 3, numerous CenterWell Home Health branches across the country will be collecting food and funds to benefit local food ba...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Molina Healthcare Announces Third Quarter 2025 Earnings Release and Conference Call Dates
News Preview
Molina Healthcare, Inc. (NYSE: MOH) today announced it will issue its earnings release for the third quarter ending September 30, 2025, after the market closes on Wednesday, October 22, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, October 23, 2025, at 8:00 a.m. Eastern Time. To access this interact...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: CA45257F2008
ImmunoPrecise Antibodies Ltd.
IPA
LISTED
NASDAQ
ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”
News Preview
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), ImmunoPrecise Antibodies Ltd. and its subsidiaries (BioStrand and Talem) today announced a unification under a single corporate brand, MindWalk, and a change of its Nasdaq ticker symbol to HYFT. The new identity conveys the Company’s evolution into a Bio-Native AI platform busin...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US22407B1089
Coya Therapeutics, Inc.
COYA
LISTED
NASDAQ
Coya Therapeutics to Participate at Upcoming September Investor Conferences
News Preview
HOUSTON, Sept. 3, 2025 /PRNewswire/ -- Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, announces the company's management team will participate in two upcoming invest...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
AbbVie Announces Updated Results From Phase 2 EPCORE® NHL-6 Study Evaluating the Potential for Outpatient Monitoring of Epcoritamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
News Preview
Data presented at 13th Society of Hematologic Oncology (SOHO) Annual MeetingNORTH CHICAGO, Ill., Sept. 3, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced updated results from the Phase 2 EPCORE® NHL-6 trial (NCT05451810) evaluating the feasibility of dosing and monitoring patients in the outpatient setting for the first full dose of epco...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
Updated flu vaccinations now available at CVS Pharmacy® and MinuteClinic®
News Preview
CVS Health® survey finds more than 60 percent of consumers say they are likely to get a flu shot this season
Enhanced flu testing and treatment offerings are also available in select CVS Pharmacy locations across 38 states
WOONSOCKET, R.I., Sept. 3, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that updated 2025-2026 flu vaccines a...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US29405E2081
Enveric Biosciences, Inc.
ENVB
LISTED
NASDAQ
Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced that Director and CEO, Joseph Tucker, Ph.D., will deliver a virtual presentation at the H.C. Wainwright 27th Annual Global Investment...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
ISIN: US3723032062
Genmab A/S
GMAB
LISTED
NASDAQ
Genmab Announces Updated Results from Phase 2 EPCORE® NHL-6 Study Evaluating Epcoritamab Monotherapy in the Outpatient Setting in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
News Preview
Genmab A/S (Nasdaq: GMAB) today announced updated results from the Phase 2 EPCORE® NHL-6 trial (NCT05451810) evaluating the safety and efficacy of investigational epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, as a monotherapy administered in the outpatient setting in adult patients with relapsed/refractory (R/R) d...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: GB0009223206
Smith & Nephew PLC
SN
LISTED
LSE
Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the CENTRIO Platelet-Rich-Plasma (PRP) System, a biodynamic hematogel derived from a patient’s own platelets and plasma that, once applied, may assist the natural healing process by maintaining a moist wound environment. ...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
